Gsk (GSK) Acquisitions (2009 - 2026)
Gsk (GSK) posted quarterly Acquisitions of -$1.9 billion for Q1 2026, down 87.86% year-over-year from -$15.6 billion in Q1 2025, and down 77.88% quarter-over-quarter from -$1.1 billion in Q4 2025.
Gsk (GSK) Acquisitions (2009 - 2026) Analysis & Trends
Gsk's Acquisitions history runs 18 years deep, the most recent figure standing at -$1.9 billion for Q1 2026.
- In Q1 2026, Acquisitions fell 87.86% year-over-year to -$1.9 billion; the TTM figure through Mar 2026 stood at -$4.9 billion (down 6.68% YoY), while the FY2025 annual figure was -$2.2 billion, down 116.8% from the prior year.
- Acquisitions for Q1 2026 stood at -$1.9 billion, down from -$1.1 billion in the prior quarter.
- The five-year high for Acquisitions was $14.7 billion in Q1 2022, with the low at -$1.9 billion in Q1 2026.
- The 5-year median for Acquisitions is -$960.1 million (2024), against an average of $2.0 billion.
- The sharpest annual moves came in 2022 and 2024: Acquisitions soared 124.34% in 2022, then plunged 125.96% in 2024.
- Gsk's Acquisitions stood at $7.6 billion in 2022, then slumped by 122.9% to -$1.7 billion in 2023, then jumped by 44.71% to -$960.1 million in 2024, then retreated by 10.84% to -$1.1 billion in 2025, then sank by 77.88% to -$1.9 billion in 2026.
- Business Quant data shows GSK's Acquisitions at -$1.9 billion in Q1 2026, -$1.1 billion in Q4 2025, and -$1.0 billion in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -17.24 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 11.21 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.89 Bn |
| Dec 31, 2025 | -1.06 Bn |
| Mar 31, 2025 | -1.01 Bn |
| Dec 31, 2024 | -960.06 Mn |
| Mar 31, 2024 | -912.06 Mn |
| Dec 31, 2023 | -1.74 Bn |
| Mar 31, 2023 | 3.51 Bn |
| Dec 31, 2022 | 7.58 Bn |
| Mar 31, 2022 | 14.72 Bn |
| Dec 31, 2021 | 4.72 Bn |
| Mar 31, 2021 | 6.56 Bn |
| Dec 31, 2020 | -6.26 Bn |
| Sep 28, 2020 | -7.60 Mn |
| Mar 31, 2020 | 6.11 Bn |
| Dec 31, 2019 | -4.68 Bn |
| Sep 30, 2019 | 114.69 Mn |
| Mar 31, 2019 | -4.74 Bn |
| Dec 31, 2018 | 5.21 Bn |
| Mar 31, 2018 | 5.57 Bn |
| Dec 31, 2017 | 5.29 Bn |